CA2066699A1 - Biomaterial based on collagen and its applications - Google Patents

Biomaterial based on collagen and its applications

Info

Publication number
CA2066699A1
CA2066699A1 CA2066699A CA2066699A CA2066699A1 CA 2066699 A1 CA2066699 A1 CA 2066699A1 CA 2066699 A CA2066699 A CA 2066699A CA 2066699 A CA2066699 A CA 2066699A CA 2066699 A1 CA2066699 A1 CA 2066699A1
Authority
CA
Canada
Prior art keywords
collagen
applications
biomaterial
support
biomaterial based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2066699A
Other languages
French (fr)
Other versions
CA2066699C (en
Inventor
Estelle Tinois
Jerome Tiollier
Henri Dumas
Michel Tardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imedex SA
Sanofi Pasteur SA
Original Assignee
Estelle Tinois
Jerome Tiollier
Henri Dumas
Michel Tardy
Imedex
Pasteur Merieux Serums Et Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estelle Tinois, Jerome Tiollier, Henri Dumas, Michel Tardy, Imedex, Pasteur Merieux Serums Et Vaccins filed Critical Estelle Tinois
Publication of CA2066699A1 publication Critical patent/CA2066699A1/en
Application granted granted Critical
Publication of CA2066699C publication Critical patent/CA2066699C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Abstract

The biomaterial based on collagen comprises, intimately associated, a support or dermal substitute based on type IV
collagen and an epidermal epithelium having differentiated cells obtained by the growth of epidermal cells on said support or dermal substitute.
This biomaterial has applications in tests in vitro in toxicology, pharmacology, or cosmetology or as a protection of wounds and burns or as a cicatrisation agent.
CA002066699A 1990-10-02 1991-10-02 Biomaterial based on collagen and its applications Expired - Lifetime CA2066699C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9012135 1990-10-02
FR9012135A FR2667246A1 (en) 1990-10-02 1990-10-02 BIOMATERIAL BASED ON COLLAGEN AND APPLICATIONS.

Publications (2)

Publication Number Publication Date
CA2066699A1 true CA2066699A1 (en) 1992-04-03
CA2066699C CA2066699C (en) 1998-08-25

Family

ID=9400861

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002066699A Expired - Lifetime CA2066699C (en) 1990-10-02 1991-10-02 Biomaterial based on collagen and its applications

Country Status (10)

Country Link
EP (1) EP0502172B1 (en)
JP (1) JP2773058B2 (en)
AT (1) ATE157120T1 (en)
CA (1) CA2066699C (en)
DE (1) DE69127353T2 (en)
DK (1) DK0502172T3 (en)
ES (1) ES2106086T3 (en)
FR (1) FR2667246A1 (en)
GR (1) GR3025180T3 (en)
WO (1) WO1992006179A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763255A (en) * 1994-04-25 1998-06-09 Becton Dickinson And Company Inducing epithelial cell differentiation with dried native fibrillar collagen
JP3377354B2 (en) * 1995-12-25 2003-02-17 株式会社メニコン Artificial skin
FR2744133A1 (en) * 1996-01-30 1997-08-01 Imedex METHOD FOR CULTURING CELLS WITH ANGIOGENIC POTENTIAL TO INDUCE VASCULAR MORPHOGENESIS OF SAID CELLS, IN VITRO MODELS OF VASCULAR MORPHOGENESE THUS OBTAINED, AND THEIR APPLICATIONS, IN PARTICULAR TO DRUG SCREENING
FR2792728B1 (en) * 1999-04-20 2003-05-09 Oreal METHOD FOR EVALUATING THE EFFECT OF A PRODUCT ON THE LIPOGENESIS OF THE EPIDERMIS
US20020095157A1 (en) 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
FR2799650B1 (en) 1999-10-14 2001-12-07 Oreal PROCESS FOR LIMITING THE PENETRATION IN THE SKIN AND / OR KERATINIC FIBERS OF AN ACTIVE COSMETIC AND / OR PHARMACEUTICAL AGENT
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US20040078090A1 (en) 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
FR2889808B1 (en) 2005-08-17 2011-07-22 Oreal USE OF 8-HEXADECENE-1,16-DICARBOXYLIC ACID AS A CARE AGENT TO PROMOTE COHESION OF THE CORNEA LAYER
JP2007313333A (en) * 2007-06-08 2007-12-06 Kao Corp Method for developing reconstructed skin
JP2012205516A (en) 2011-03-29 2012-10-25 Osaka Univ Method for producing artificial skin model, and artificial skin model
EP2894219B1 (en) 2012-09-04 2018-03-28 Osaka University Artificial skin tissue, artificial skin model and manufacturing method therefor
FR3054449B1 (en) 2016-07-29 2018-08-31 L'oreal EQUIVALENT OF SKIN WITH DERMAL COMPARTMENTS SEPARATE JUXTAPOSES
FR3071512B1 (en) 2017-09-28 2022-02-25 Oreal MOLECULAR SIGNATURES OF THREE SUB-POPULATIONS OF DERMAL FIBROBLASTS AND DERMIS EQUIVALENT COMPRISING ONE OF THESE SUB-POPULATIONS
US20220290107A1 (en) 2019-08-29 2022-09-15 National University Corporation Ehime University Method for producing cultured tissue, and preparation for external application
FR3111904B1 (en) 2020-06-30 2022-10-21 Oreal Bioink for bioprinting of an invaginated dermal-epidermal junction model
EP4159250A1 (en) * 2021-09-30 2023-04-05 Korea University Research and Business Foundation Method of enhancing structural integrity of epidermis in culture of reconstructed human skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604346A (en) * 1984-10-09 1986-08-05 Massachusetts Institute Of Technology Skin-equivalent prepared by the use of punch biopsy
JPH0655218B2 (en) * 1986-01-14 1994-07-27 株式会社アドバンス Artificial basement membrane and method for producing the same
JPS62246371A (en) * 1986-04-19 1987-10-27 株式会社　高研 Artificial skin and its production
FR2612939B1 (en) * 1987-03-26 1989-06-23 Cird SKIN EQUIVALENT
FR2612938B1 (en) * 1987-03-26 1989-06-23 Cird METHOD FOR OBTAINING A SKIN EQUIVALENT AND CORRESPONDING SKIN EQUIVALENT
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
FR2628634B1 (en) * 1988-03-15 1990-07-13 Imedex VISCERAL SURGERY PATCH
JPH04129563A (en) * 1990-09-19 1992-04-30 Terumo Corp Artificial skin and its manufacture

Also Published As

Publication number Publication date
ATE157120T1 (en) 1997-09-15
DE69127353T2 (en) 1997-12-18
CA2066699C (en) 1998-08-25
FR2667246B1 (en) 1995-06-02
FR2667246A1 (en) 1992-04-03
JPH05504085A (en) 1993-07-01
ES2106086T3 (en) 1997-11-01
WO1992006179A1 (en) 1992-04-16
EP0502172B1 (en) 1997-08-20
DK0502172T3 (en) 1997-10-27
GR3025180T3 (en) 1998-02-27
EP0502172A1 (en) 1992-09-09
JP2773058B2 (en) 1998-07-09
DE69127353D1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
CA2066699A1 (en) Biomaterial based on collagen and its applications
CA2154264A1 (en) Alginate fibres with improved absorbency
CA2011171A1 (en) Biodegradable Poly (Phosphate Esters)
AU7097094A (en) Carbohydrate-modified polymer conjugates with erythropoietic activity
EP1398370A3 (en) In-vitro micro-organs
AU6225490A (en) Photoprotection compositions having reduced dermal irritation
AU4029693A (en) Polymer compositions and their production, in particular absorbent materials, and their use
AU5061999A (en) Slow release formulations comprising anionic polysaccharide
CA2028570A1 (en) Antimicrobial method and formulation employing type ii endoglycosidase and antimicrobial agent
AU4029593A (en) Polymer composition, absorbent material composition, their production and their use
AU698910B2 (en) Ethylene copolymers having narrow composition distribution, their production and use
CA2126087A1 (en) Composite membranes for the guided regeneration of tissues
CA2184433A1 (en) Retinoid Formulations in Porous Microspheres for Reduced Irritation and Enhanced Stability
CA2126085A1 (en) Non-woven fabric material comprising hyaluronic acid derivatives
CA2279270A1 (en) Polyesteramides with amino acid-derived groups alternating with alpha-hydroxyacid-derived groups and surgical articles made therefrom
EP2093245A3 (en) Biocompatible polymer device
AU8024291A (en) Oligomers, their uses and formulations
CA2301176A1 (en) Self-binding shearform compositions
AU9075591A (en) N-halochitosans, their preparation and uses
CA2146734A1 (en) Method for long term subculture of dermal papilla cells
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
AU2307895A (en) Collagen preparation for the controlled release of active substances
AU5761499A (en) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
CA2048638A1 (en) Fibroblast growth factor (fgf)-based stabilized compositions and the use thereof
AU7559691A (en) 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry